Microbial contract biomanufacturing market is growing at a CAGR of 8.7%, <claims Roots>
Although hazardous reaction chemistries are not used during early drug development stages owing to the associated risks, they offer a wide range of benefits over traditional approaches, especially from the perspective of large-scale manufacturing   Roots Analysis is pleased to announce the publication of its recent study, titled, “High Energy Chemistry / Hazardous Chemistry-based API...
0 Σχόλια 0 Μοιράστηκε